Đang chuẩn bị liên kết để tải về tài liệu:
Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: A retrospective, nationwide, population-based cohort study
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Small-cell lung cancer (SCLC) is a highly proliferative, rapidly growing tumor with a poor prognosis, even in cases of limited disease (LD). Timely and accurate high-intensity therapy is necessary. For concurrent chemoradiotherapy (CCRT), etoposide/platinum (EP)-based regimens are recommended, although irinotecan/ platinum (IP)-based regimens are also effective with radiotherapy. |